DNA binding ligands targeting drug-resistant Gram-positive bacteria.: Part 2:: C-terminal benzimidazoles and derivatives

被引:63
|
作者
Bürli, RW [1 ]
Jones, P [1 ]
McMinn, D [1 ]
Le, Q [1 ]
Duan, JX [1 ]
Kaizerman, JA [1 ]
Difuntorum, S [1 ]
Moser, HE [1 ]
机构
[1] Genesoft Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
antibiotics; DNA binder; minor groove; lead optimization;
D O I
10.1016/j.bmcl.2003.12.043
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and in vitro potency of DNA minor-groove binding antibacterials lacking the C-terminal amide bond are described. The crescent shaped molecules bear the positively charged amino group at an internal pyrrole unit instead of the C-terminus. Three structural parameters were investigated: the N-terminal unit, the internal amino group, and the C-terminal ring system. Several compounds demonstrated good in vitro potency against various Gram-positive bacteria and some molecules were moderately active against Escherichia coli, a representative Gram-negative strain. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1259 / 1263
页数:5
相关论文
共 29 条
  • [1] DNA binding ligands targeting drug-resistant gram-positive bacteria.: Part 1:: Internal benzimidazole derivatives
    Bürli, RW
    McMinn, D
    Kaizerman, JA
    Hu, WH
    Ge, YG
    Pack, Q
    Jiang, V
    Gross, M
    Garcia, M
    Tanaka, R
    Moser, HE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1253 - 1257
  • [2] DNA binding ligands with excellent antibiotic potency against drug-resistant Gram-positive bacteria
    Bürli, RW
    Ge, YG
    White, S
    Baird, EE
    Touami, SM
    Taylor, M
    Kaizerman, JA
    Moser, HE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (18) : 2591 - 2594
  • [3] The management of infections due to drug-resistant gram-positive bacteria
    R. C. Moellering
    European Journal of Clinical Microbiology and Infectious Diseases, 2005, 24 : 777 - 779
  • [4] The management of infections due to drug-resistant gram-positive bacteria
    Moellering, RC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (12) : 777 - 779
  • [5] New treatments for multiply drug-resistant Gram-positive bacteria
    Moellering, Robert C., Jr.
    JOURNAL OF INFECTION, 2009, 59 : S1 - S3
  • [6] DNA binding ligands targeting drug-resistant bacteria:: Structure, activity, and pharmacology
    Kaizerman, JA
    Gross, ML
    Ge, YG
    White, S
    Hu, WH
    Duan, JX
    Baird, EE
    Johnson, KW
    Tanaka, RD
    Moser, HE
    Bürli, RW
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) : 3914 - 3929
  • [7] Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria
    Eliopoulos, George M.
    JOURNAL OF INFECTION, 2009, 59 : S17 - S24
  • [8] Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
    Gokarn, Karuna
    Pal, Ramprasad B.
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 61 - 75
  • [9] C-terminal WxL domain mediates cell wall binding in Enterococcus faecalis and other gram-positive bacteria
    Brinster, Sophie
    Furlan, Sylviane
    Serror, Pascale
    JOURNAL OF BACTERIOLOGY, 2007, 189 (04) : 1244 - 1253
  • [10] Single Modification at the N-Terminus of Norvancomycin to Combat Drug-Resistant Gram-Positive Bacteria
    Guan, Dongliang
    Chen, Feifei
    Shi, Wei
    Lan, Lefu
    Huang, Wei
    CHEMMEDCHEM, 2023, 18 (09)